Effect comparison between laparoscopic combination therapy of choledochoscope and plasma lithotripsy and conventional open surgical therapy in treatment of patients with hepatolithiasis
-
摘要: 目的：探讨腹腔镜下胆道镜联合等离子碎石术治疗肝内胆管结石的疗效与安全性。方法将腹腔镜下胆道镜联合等离子碎石术治疗的28例肝内胆管结石患者设为观察组，另将同期收治的28例接受开腹手术治疗的肝内胆管结石患者设为对照组。比较2组患者主要围术期指标、术后 T 管监测指标及结石取尽率。结果观察组患者术中出血量、术后排气时间及住院时间均明显短于对照组，差异有统计学意义（P ＜0．05）；观察组患者在术后第3天起，T 管引流量及胆管压力均显著小于对照组，差异有统计学意义（P ＜0．05）；观察组结石取尽率为92．86％，明显高于对照组的78．57％，差异有统计学意义（P ＜0．05）。结论腹腔镜下胆道镜联合等离子碎石术治疗肝内胆管结石具有直观、微创、残石率低及安全等优点，值得临床推广应用。Abstract: Objective To explore the efficacy and safety of laparoscopic combination thera-py of choledochoscope and plasma lithotripsy in treatment of patients with hepatolithiasis.Methods 28 hepatolithiasis patients treated with laparoscopic combination therapy of choledochoscope and plasma lithotripsy were collected and designed as observation group,and 28 28 hepatolithiasis pa-tients treated with open surgical therapy were collected and designed as control group.The major perioperative and postoperative T-tube monitoring indicators as well as residual stone rate were compared between two groups.Results The blood loss,postoperative exhaust time and hospital stay in the observation group were significantly less and shorter than those in the control group (P<0.05).The T-tube drainage and duct pressure in the observation group from the third day af-ter operation were significantly less than the control group (P <0.05).Residual stone rate in ob-servation group was 92.86 %,which was significantly higher than 78.57% in the control group (P < 0.05 ).Conclusion Laparoscopic combination therapy of choledochoscope and plasma lithotripsy shows a series of advantages such as intuitive,minimally invasive,low residual stone rate and safety in treatment of hepatolithiasis,so it is worthy of clinical application and populariza-tion.
-
Keywords:
- hepatolithiasis /
- laparoscopy /
- choledochoscope /
- plasma lithotripsy
-
-
期刊类型引用(11)
1. 刘亚男，房志琴，郭健宏，王亚玲. 冠状动脉慢血流患者血清Lp-PLA_2、NLR水平变化及临床意义. 广东医学. 2024(06): 717-722 . 
百度学术
2. 朱雅男，张志强，徐继方，朱云霞，安梦秋. 冠状动脉慢血流的相关血清学分析. 心肺血管病杂志. 2023(01): 23-26 . 百度学术
3. 孙晓慧，贺静，王瑶，白蓉，薛晓珍，杨莉，乌宇亮. 血清脂蛋白相关磷脂酶A2水平与冠状动脉病变程度及慢血流的相关性分析. 临床医学研究与实践. 2023(26): 9-12 . 百度学术
4. 师志芳，贾营，张秀敬，谭化，王爱民，赵洁. 血清血小板活化因子和脂蛋白相关磷脂酶AA2对冠状动脉慢血流现象的预测价值分析. 中国心血管病研究. 2023(12): 1080-1085 . 百度学术
5. 梁万添，唐良秋，陈锦峰，庞军刚，周婉明，陈伟强，陈姣. 小檗碱对急性心肌梗死经皮冠状动脉介入术后冠状动脉不稳定斑块的治疗作用. 中国医药. 2021(01): 28-32 . 百度学术
6. 刘玲玲，韩磊. 冠状动脉慢血流与超敏CRP及左室舒张功能的相关性研究. 中国医药指南. 2021(22): 11-13 . 百度学术
7. 朱宝华，孙岩. 冠状动脉疾病差异基因富集和加权基因共表达网络分析. 实用临床医药杂志. 2021(17): 15-21 . 本站查看
8. 陶金松，李健，徐霞，陆翊超，李伟章. 冠心病患者介入术中并发冠状动脉慢血流的影响因素. 现代医学与健康研究电子杂志. 2021(19): 93-95 . 百度学术
9. 陆爱民，童有福，赵艳. 利伐沙班对冠状动脉慢血流患者凝血功能及C反应蛋白的影响. 医学综述. 2021(21): 4354-4359 . 百度学术
10. 孙涛，张艳丽，侯梅凤，姚成俊，潘闽. 血清脂蛋白(a)[Lp(a)]、血清超敏C反应蛋白（hs-CRP）与冠状动脉慢血流之间的相关性. 系统医学. 2021(22): 32-36 . 百度学术
11. 陈艳俏，程伟，张成英，陈少军，马友合，孙久林. 保元汤合桂枝茯苓丸治疗冠状动脉慢血流临床观察. 中国中医药现代远程教育. 2020(19): 70-73 . 百度学术
其他类型引用(0)
计量
- 文章访问数: 155
- HTML全文浏览量: 30
- PDF下载量: 0
- 被引次数: 11
下载:
苏公网安备 32100302010246号
